Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | CES1 | P23141 | 1/20 | 0.55 |
| ▸ | GRM4 | Q14833 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.53 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4508472 | 0.88 | CES2 (0.64) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL28727383 | 0.86 | CES2 (0.61) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8597610 | 0.82 | LMNA (0.61) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL21792059 | 0.81 | CES2 (0.52) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL3188677 | 0.81 | ALDH1A1 (0.62) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8779235 | 0.80 | SMYD3 (0.54) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL109657 | 0.80 | HDAC3 (0.61) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7989152 | 0.80 | HDAC1 (0.77) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL28131851 | 0.80 | HDAC3 (0.61) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL2747054 | 0.80 | ALDH1A1 (0.51) | HDAC6HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190157599-A1 | THIN FILM AND ORGANIC ELECTROLUMINESCENT ELEMENT | MERCK PATENT GMBH (DE) | 2019-05-23 | — | — | US | disclosed |
| EP-1887416-B1 | ELECTROCHROMIC DISPLAY ELEMENT AND FULL-COLOR ELECTROCHROMIC DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS INC (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-8765309-B2 | Electrochemical device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8437067-B2 | Electrochemical display element | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-05-07 | — | — | US | disclosed |
| US-20110266945-A1 | DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-11-03 | — | — | US | disclosed |
| US-20110143211-A1 | ELECTROCHEMICAL DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-06-16 | — | — | US | disclosed |
| US-20110058244-A1 | ELECTROCHROMIC DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-03-10 | — | — | US | disclosed |
| US-20110019265-A1 | DISPLAY ELEMENT AND METHOD OF FORMING POROUS LAYER IN DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-27 | — | — | US | disclosed |
| US-20110013261-A1 | ELECTROCHEMICAL DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-01-20 | — | — | US | disclosed |
| US-20100097684-A1 | DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-04-22 | — | — | US | disclosed |
| US-7005251-B2 | Silver salt photothermographic dry imaging material, image recording method and image forming method for the same | KONICA MINOLTA HOLDINGS, INC. (JP) | 2006-02-28 | — | — | US | disclosed |
| US-20040115569-A1 | Photothermographic imaging material and method for forming image | KONICA MINOLTA HOLDINGS, INC. (JP) | 2004-06-17 | — | — | US | disclosed |
| US-20040106074-A1 | Silver salt photothermographic dry imaging material, image recording method and image forming method for the same | KONICA MINOLTA HOLDINGS, INC. (JP) | 2004-06-03 | — | — | US | disclosed |
| US-20040101794-A1 | Photothermographic imaging material | KONICA MINOLTA HOLDINGS, INC. (JP) | 2004-05-27 | — | — | US | disclosed |
| EP-1422552-A2 | Silver salt photothermographic dry imaging material, image recording method and image forming method for the same | KONICA MINOLTA HOLDINGS, INC. (JP) | 2004-05-26 | — | — | EP | disclosed |
| US-5340707-A | Containing specified pyrazolone dye; storage stability | KONICA CORPORATION (JP) | 1994-08-23 | — | — | US | disclosed |
| US-5106843-A | Treatment of migraine, emesis, anxiety, gastrointestinal disorders, psychological disorders | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-04-21 | — | — | US | disclosed |
| EP-0323077-B1 | HETEROCYCLIC COMPOUNDS | JOHN WYETH & BROTHER LIMITED (GB) | 1991-09-11 | — | — | EP | disclosed |
| US-4983600-A | Antiemetics, antianxiety agents, gastrointestinal disorders | JOHN WYETH & BROTHER LIMITED (GB) | 1991-01-08 | — | — | US | disclosed |
| EP-0323077-A1 | Heterocyclic compounds | JOHN WYETH & BROTHER LIMITED (GB) | 1989-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190157599-A1 | THIN FILM AND ORGANIC ELECTROLUMINESCENT ELEMENT | ETFA, EEA1, EEF1A1 | HDAC6 4102/4885HDAC3 4838/4885HDAC4 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.